NantHealth (NH) versus Greenway Health (GWAY) Financial Survey

NantHealth (NASDAQ: NH) and Greenway Health (NYSE:GWAY) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability and institutional ownership.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for NantHealth and Greenway Health, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NantHealth 0 0 4 0 3.00
Greenway Health 0 0 0 0 N/A

NantHealth presently has a consensus price target of $9.00, suggesting a potential upside of 197.03%.

Earnings and Valuation

This table compares NantHealth and Greenway Health’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
NantHealth $100.38 million 3.27 -$184.10 million ($1.78) -1.70
Greenway Health N/A N/A N/A ($0.17) N/A

Greenway Health has lower revenue, but higher earnings than NantHealth. NantHealth is trading at a lower price-to-earnings ratio than Greenway Health, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares NantHealth and Greenway Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
NantHealth -225.76% -46.09% -25.23%
Greenway Health N/A N/A N/A

Insider and Institutional Ownership

7.1% of NantHealth shares are owned by institutional investors. 58.0% of NantHealth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

About NantHealth

NantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. The Company also offers Nant Operating System (NantOS) and NantOS applications to healthcare providers and payors, self-insured employers and biopharmaceutical companies. It offers CLINICS, an integrated solution that includes GPS Cancer, NantOS and the NantOS applications. The CLINICS solution includes System Infrastructure, Knowledge Platform, Provider Platform and Payor Platform.

About Greenway Health

Greenway Health LLC is a United States-based company, which provides clinical, financial and administrative solutions for healthcare providers. The Company provides integrated clinically driven revenue cycle management and electronic health record (EHR) solutions. Its suite of solutions and services is PrimeSUITE, which integrates clinical, financial and administrative data in a single database to enable views of patient records and workflow throughout each patient encounter, reduce clinical and administrative errors, and allow for the exchange of data between its customers and the healthcare community. It offers its solutions by offering managed business services, such as clinically-driven revenue cycle and EHR-enabled research services.

What are top analysts saying about NantHealth Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for NantHealth Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit